The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial.
In the randomized, placebo-controlled, physician-blinded Canadian cooperative trial of cyclophosphamide and plasma exchange, neither active treatment regimens (group I: i.v. cyclophosphamide and prednisone; group II: weekly plasma exchange, oral cyclophosphamide, and prednisone) were superior to pla...
Κύριοι συγγραφείς: | Noseworthy, J, Ebers, G, Vandervoort, M, Farquhar, R, Yetisir, E, Roberts, R |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
1994
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial. 1994 [classical article]
ανά: Noseworthy, J, κ.ά.
Έκδοση: (2001) -
The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial
ανά: Nosworthy, J, κ.ά.
Έκδοση: (2001) -
ACCEPTANCE OF PLACEBO-CONTROL TRIAL DESIGN BY PROGRESSIVE MULTIPLE-SCLEROSIS PATIENTS
ανά: Noseworthy, J, κ.ά.
Έκδοση: (1989) -
Acceptance of placebo-control trial design by progressive multiple sclerosis patients. The Canadian Cooperative Multiple Sclerosis Study Group.
ανά: Noseworthy, J, κ.ά.
Έκδοση: (1989) -
A referendum on clinical trial research in multiple sclerosis: the opinion of the participants at the Jekyll Island workshop.
ανά: Noseworthy, J, κ.ά.
Έκδοση: (1989)